These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 38805086)

  • 1. Measuring the impact of pharmaceutical care bundle delivery on patient outcomes: an observational study.
    Canning ML; McDougall R; Yerkovich S; Barras M; Coombes I; Sullivan C; Whitfield K
    Int J Clin Pharm; 2024 May; ():. PubMed ID: 38805086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defining quality indicators, pharmaceutical care bundles and outcomes of clinical pharmacy service delivery using a Delphi consensus approach.
    Canning ML; Barras M; McDougall R; Yerkovich S; Coombes I; Sullivan C; Whitfield K
    Int J Clin Pharm; 2024 Apr; 46(2):451-462. PubMed ID: 38240963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of disinvestment from weekend allied health services across acute medical and surgical wards: 2 stepped-wedge cluster randomised controlled trials.
    Haines TP; Bowles KA; Mitchell D; O'Brien L; Markham D; Plumb S; May K; Philip K; Haas R; Sarkies MN; Ghaly M; Shackell M; Chiu T; McPhail S; McDermott F; Skinner EH
    PLoS Med; 2017 Oct; 14(10):e1002412. PubMed ID: 29088237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protocol for a randomised controlled trial evaluating the impact of a community pharmacy discharge medication reconciliation service on unplanned hospital readmissions - The DCMedsRec trial.
    Duncan G; Ngo C; Fanning L; Taylor DA; McNamara K; Caliph S; Suen B; Johnston S; Darzins P
    Res Social Adm Pharm; 2021 Feb; 17(2):460-465. PubMed ID: 32273252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modified-frailty index does not independently predict complications, hospital length of stay or 30-day readmission rates following posterior lumbar decompression and fusion for spondylolisthesis.
    Elsamadicy AA; Freedman IG; Koo AB; David WB; Reeves BC; Havlik J; Pennington Z; Kolb L; Shin JH; Sciubba DM
    Spine J; 2021 Nov; 21(11):1812-1821. PubMed ID: 34010683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inpatient pharmacists using a readmission risk model in supporting discharge medication reconciliation to reduce unplanned hospital readmissions: a quality improvement intervention.
    Gallagher D; Greenland M; Lindquist D; Sadolf L; Scully C; Knutsen K; Zhao C; Goldstein BA; Burgess L
    BMJ Open Qual; 2022 Mar; 11(1):. PubMed ID: 35241436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of 30-day postdischarge hospital readmission or emergency department (ED) visit rates in high-risk elderly medical patients through delivery of a targeted care bundle.
    Koehler BE; Richter KM; Youngblood L; Cohen BA; Prengler ID; Cheng D; Masica AL
    J Hosp Med; 2009 Apr; 4(4):211-8. PubMed ID: 19388074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of medication bedside delivery program on hospital readmission rates.
    Witcraft EJ; Norris AM; Fudzie SS; Vest MH; Johnson N; Rush J; Colmenares EW
    J Am Pharm Assoc (2003); 2021; 61(1):95-100.e1. PubMed ID: 33199165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Clinical Pharmacists-driven Bundled Activities from Admission to Discharge on 90-day Hospital Readmissions and Emergency Department Visits.
    Al Abd BM; Al-Maqbali JS; Al-Zakwani I
    Oman Med J; 2023 Nov; 38(6):e566. PubMed ID: 38264514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality indicators of hospitalized children influenced by clinical pharmacist services: A systematic review.
    Alcântara TDS; Carvalho GAC; Sanchez JM; Ramos SF; Cunha LC; Araújo-Neto FC; Valença-Feitosa F; Silvestre CC; Lyra Junior DP
    Res Social Adm Pharm; 2023 Oct; 19(10):1315-1330. PubMed ID: 37442709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors associated with unplanned readmissions in a major Australian health service.
    Considine J; Fox K; Plunkett D; Mecner M; O Reilly M; Darzins P
    Aust Health Rev; 2019 Feb; 43(1):1-9. PubMed ID: 29092726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of early in-hospital medication review by clinical pharmacists on health services utilization.
    Hohl CM; Partovi N; Ghement I; Wickham ME; McGrail K; Reddekopp LN; Sobolev B
    PLoS One; 2017; 12(2):e0170495. PubMed ID: 28192477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Association Between Hospital Length of Stay and 90-Day Readmission Risk Within a Total Joint Arthroplasty Bundled Payment Initiative.
    Williams J; Kester BS; Bosco JA; Slover JD; Iorio R; Schwarzkopf R
    J Arthroplasty; 2017 Mar; 32(3):714-718. PubMed ID: 27776899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of pharmacist-led medication management in care transitions.
    Yang S
    BMC Health Serv Res; 2017 Nov; 17(1):722. PubMed ID: 29132369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Targeted Pharmacist Interventions to Reduce Length of Stay in an Acute Care Practice Model.
    Leary MH; Morbitzer K; Walston BJ; Clark S; Kaplan J; Waldron K; Valgus J; Falato C; Amerine L
    Ann Pharmacother; 2019 May; 53(5):471-477. PubMed ID: 30449133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of pharmacy interventions at transitions of care on patient outcomes.
    Fosnight S; King P; Ewald J; Feucht J; Lamtman A; Kropp D; Dittmer A; Sampson J; Shah M
    Am J Health Syst Pharm; 2020 Jun; 77(12):943-949. PubMed ID: 32374386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of the population health inpatient Medicare Advantage pharmacist intervention on hospital readmissions: A quasi-experimental controlled study.
    Nguyen AT; Wisniewski J; Leang DW; Keller MS; Rosen S; Shane R; Pevnick JM
    J Manag Care Spec Pharm; 2023 Mar; 29(3):266-275. PubMed ID: 36840959
    [No Abstract]   [Full Text] [Related]  

  • 19. Patient- and hospital-related risk factors for non-routine discharge after lumbar decompression and fusion for spondylolisthesis.
    Elsamadicy AA; Freedman IG; Koo AB; David W; Hengartner AC; Havlik J; Reeves BC; Hersh A; Pennington Z; Kolb L; Laurans M; Shin JH; Sciubba DM
    Clin Neurol Neurosurg; 2021 Oct; 209():106902. PubMed ID: 34481141
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.